EMD-8573

Single-particle
28.1 Å
EMD-8573
3D View Gallery
Deposition: 23/01/2017
Map released: 08/03/2017
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-8573
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial

EMD-8573

Single-particle
28.1 Å
EMD-8573
3D View Gallery
Deposition: 23/01/2017
Map released: 08/03/2017
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial

Deposition Authors: Fera D, Harrison SC
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
Easterhoff D , Moody MA , Fera D , Cheng H , Ackerman M, Wiehe K , Saunders KO, Pollara J, Vandergrift N , Parks R, Kim J , Michael NL, O'Connell RJ, Excler JL , Robb ML , Vasan S, Rerks-Ngarm S, Kaewkungwal J , Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J , Phogat S, Kepler TB , Alam SM, Liao HX, Ferrari G , Seaman MS, Montefiori DC, Tomaras GD , Harrison SC, Haynes BF
(2017) Plos Pathog , 13 , e1006182 - e1006182
PUBMED: 28235027
DOI: doi:10.1371/journal.ppat.1006182
ISSN: 1553-7374